Skip to content
Private EquityRIA · CRD 160448Exempt Reporting AdviserPrivate Fund Adviser

Updated:

Telegraph Hill Partners

Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives.

Telegraph Hill Partners logo

Telegraph Hill Partners

Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. It partners with private life science and healthcare companies that have novel technologies, a solid customer base, and innovative management teams, providing capital and strategic guidance.

General information

Firm type

Private Equity

Year founded

2001

Location

Region

North America

Country

United States

City

San Francisco

Corporate office

San Francisco, CA, United States

Principals

Deval A. Lashkari

Ph.D., Senior Partner

Rob C. Hart

J.D., CFA, Partner

Gary D. Curtis

Senior Advisor

Anthony Manupella

Controller

Sector focus

Life Sciences

Frequently asked questions

Does Telegraph Hill Partners participate in fund commitments or only direct deals?

All publicly available information describes direct investment activity — growth equity rounds, management buyouts, and founder liquidity deals — with no mention of fund-of-fund commitments or allocations to external managers. The firm's strategy page emphasizes being the lead or sole institutional investor, reinforcing a direct-only approach.

How is Telegraph Hill Partners structured — does it operate more like a venture firm or a traditional buyout shop?

The firm occupies a hybrid position: it writes equity checks into revenue-stage companies, resembling growth equity, but also pursues management buyouts and corporate carve-outs, which are hallmarks of traditional private equity. This dual capability, confined to a single sector vertical, differentiates it from both generalist venture firms and multi-sector mid-market buyout funds.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Source record modified: . Public records carry source-specific dates where available. No population-wide measured refresh cadence or universal verification deadline is established here. Page modified, source captured, fact observed, entity verified and aggregate measured describe different events. Check the date attached to the relevant claim; a missing verification date means unknown. Stored source history does not establish a customer-facing historical-analysis interface. To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Private Equity profiles